These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

13309 related items for PubMed ID: 11690551

  • 1. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 3. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V, Gimmnich P, Hofmann HP, Grebe C, Römmele M, Leja A, Baudler M, Benimetskaya L, Gonser B, Pieles U, Maier T, Wagner T, Sanders K, Beck JF, Hanauer G, Stein CA.
    Oligonucleotides; 2006 Apr 03; 16(1):83-93. PubMed ID: 16584297
    [Abstract] [Full Text] [Related]

  • 4. Tumor regression by combination antisense therapy against Plk1 and Bcl-2.
    Elez R, Piiper A, Kronenberger B, Kock M, Brendel M, Hermann E, Pliquett U, Neumann E, Zeuzem S.
    Oncogene; 2003 Jan 09; 22(1):69-80. PubMed ID: 12527909
    [Abstract] [Full Text] [Related]

  • 5. Significance of COX-2 expression in human renal cell carcinoma cell lines.
    Chen Q, Shinohara N, Abe T, Watanabe T, Nonomura K, Koyanagi T.
    Int J Cancer; 2004 Mar 01; 108(6):825-32. PubMed ID: 14712483
    [Abstract] [Full Text] [Related]

  • 6. Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.
    Wang XW, Yuan JH, Zhang RG, Guo LX, Xie Y, Xie H.
    World J Gastroenterol; 2001 Jun 01; 7(3):345-51. PubMed ID: 11819788
    [Abstract] [Full Text] [Related]

  • 7. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.
    Clin Cancer Res; 1998 Dec 01; 4(12):2957-66. PubMed ID: 9865906
    [Abstract] [Full Text] [Related]

  • 8. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 1997 Jul 16; 89(14):1027-36. PubMed ID: 9230884
    [Abstract] [Full Text] [Related]

  • 9. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
    Park KC, Heo JH, Jeon JY, Choi HJ, Jo AR, Kim SW, Kwon HJ, Hong SJ, Han KS.
    BMC Cancer; 2015 Jan 23; 15():19. PubMed ID: 25613585
    [Abstract] [Full Text] [Related]

  • 10. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM, Zhang H.
    Ai Zheng; 2006 Jan 23; 25(1):40-4. PubMed ID: 16405747
    [Abstract] [Full Text] [Related]

  • 11. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC, Wang X, Luo L, Dong DH, Yu QC, Wang XS, Zhao K.
    Eur Rev Med Pharmacol Sci; 2013 Jun 23; 17(12):1669-80. PubMed ID: 23832737
    [Abstract] [Full Text] [Related]

  • 12. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M.
    Clin Cancer Res; 2003 Oct 01; 9(12):4595-605. PubMed ID: 14555535
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B.
    J Natl Cancer Inst; 1997 Jan 15; 89(2):124-33. PubMed ID: 8998181
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 15. Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells.
    Iwamoto Y, Ishii K, Sasaki T, Kato M, Kanda H, Yamada Y, Arima K, Shiraishi T, Sugimura Y.
    Cancer Prev Res (Phila); 2013 Sep 01; 6(9):1000-6. PubMed ID: 23901046
    [Abstract] [Full Text] [Related]

  • 16. [Apoptosis of human gastric cancer cells induced by bcl-2 antisense oligodeoxynucleotides].
    Lu P, Chen J.
    Zhonghua Zhong Liu Za Zhi; 1999 Jul 01; 21(4):253-5. PubMed ID: 11776807
    [Abstract] [Full Text] [Related]

  • 17. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H, Chi KN, Gleave ME.
    Clin Cancer Res; 2000 May 01; 6(5):1655-63. PubMed ID: 10815883
    [Abstract] [Full Text] [Related]

  • 18. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A.
    Clin Cancer Res; 2002 Apr 01; 8(4):1277-83. PubMed ID: 11948143
    [Abstract] [Full Text] [Related]

  • 19. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
    Yang DC, Jiang X, Elliott RL, Head JF.
    Anticancer Res; 2002 Apr 01; 22(3):1513-24. PubMed ID: 12168831
    [Abstract] [Full Text] [Related]

  • 20. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.
    Cancer Res; 1998 Jan 15; 58(2):283-9. PubMed ID: 9443406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 666.